Monitoring Acidification Preceding Aβ Deposition in Alzheimer's Disease
- PMID: 40103521
- DOI: 10.1002/adhm.202404907
Monitoring Acidification Preceding Aβ Deposition in Alzheimer's Disease
Abstract
Amyloid beta (Aβ) is the primary early biomarker of Alzheimer's disease (AD), and since an acidic environment promotes Aβ aggregation, acidification plays a crucial role in AD progression. In this study, a novel acid-responsive near-infrared (NIR) fluorescent probe alongside multiple molecular biology techniques to investigate the temporal relationship between acidification and Aβ deposition, as well as the underlying mechanisms of acidification is employed. By monitoring 2- to 11-month-old APP/PS1 mice and wild-type (WT) mice, it is detected significant fluorescence signal in APP/PS1 mice beginning at 3 months preceding Aβ deposition at 5 months, and peaking at 5 months, followed by cognitive deficits at 8 months. Additionally, elevated monocarboxylate transporter 4 (MCT4) protein expression in 3-month-old APP/PS1 mice indicated disruption of astrocyte-neuron lactate shuttle (ANLS) homeostasis. Overall, this findings first demonstrate that acidification precedes Aβ deposition, peaks at the onset of Aβ deposition, and diminishes thereafter, with early acidification likely driven by the disruption of ANLS.
Keywords: Alzheimer's disease; acid‐responsive; extracellular acidification; monocarboxylate transporter 4; near‐infrared fluorescent probe.
© 2025 Wiley‐VCH GmbH.
References
-
- a) J. Jia, Y. Ning, M. Chen, S. Wang, H. Yang, F. Li, J. Ding, Y. Li, B. Zhao, J. Lyu, S. Yang, X. Yan, Y. Wang, W. Qin, Q. Wang, Y. Li, J. Zhang, F. Liang, Z. Liao, S. Wang, N. Engl. J. Med. 2024, 390, 712;
-
- b) N. J. Ashton, S. Janelidze, N. Mattsson‐Carlgren, A. P. Binette, O. Strandberg, W. S. Brum, T. K. Karikari, F. González‐Ortiz, G. Di Molfetta, F. J. Meda, E. M. Jonaitis, R. L. Koscik, K. Cody, T. J. Betthauser, Y. Li, E. Vanmechelen, S. Palmqvist, E. Stomrud, R. J. Bateman, H. Zetterberg, S. C. Johnson, K. Blennow, O. Hansson, Nat. Med. 2022, 28, 2555.
-
- Z. Qian, Z. Wang, B. Li, X. Meng, Z. Kuang, Y. Li, Y. Yang, K. Ye, Mol. Psychiatry 2024, 29, 3040.
-
- a) L. Vermunt, S. A. M. Sikkes, A. van den Hout, R. Handels, I. Bos, W. M. van der Flier, S. Kern, P. J. Ousset, P. Maruff, I. Skoog, F. R. J. Verhey, Y. Freund‐Levi, M. Tsolaki, K. Wallin Å, M. Olde Rikkert, H. Soininen, L. Spiru, H. Zetterberg, K. Blennow, P. Scheltens, G. Muniz‐Terrera, P. J. Visser, Alzheimers Dement. 2019, 15, 888;
-
- b) A. Gustavsson, N. Norton, T. Fast, L. Frölich, J. Georges, D. Holzapfel, T. Kirabali, P. Krolak‐Salmon, P. M. Rossini, M. T. Ferretti, L. Lanman, A. S. Chadha, W. M. van der Flier, Alzheimers Dement. 2023, 19, 658;
MeSH terms
Substances
Grants and funding
- 2022YFC2009901,2022YFC2009900/National Key R&D Program of China
- 22407095,82120108014,82441007/National Natural Science Foundation of China
- ZYGD23003/1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University
- 2022-GH03-00017-HZ/Chengdu Science and Technology Office, major technology application demonstration project
- CGZH21002/Scientific and Technological Achievements Transformation Fund of West China Hospital, Sichuan University
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous